Organisation paid for research Program year 2023 Source: CMS Open Payments

Michigan Headache and Neurological

Neither a doctor nor a teaching hospital

Research payments

$371,171

52 payments

Through program year 2023, Michigan Headache and Neurological is reported as receiving $371,171 in research payments, across 52 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2023	Research	$112,688	30
2022	Research	$39,940	9
2020	Research	$100,686	4
2019	Research	$117,857	9

Breakdown

Who paid Research payments · program years 2019–2023

Amgen Inc. $255,763 18 payments
AbbVie, Inc. $115,408 34 payments

Studies the money was for Research payments · program years 2019–2023

Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine $106,408 33 payments
Phase 2 Episodic Migraine Prophylaxis EMP $53,263 1 payment
Ph3 Pediatric CM Study $38,423 4 payments
Ph3 Pediatric CM Study. $36,964 1 payment
Phase P3 Pediatric Study (EM) $36,081 4 payments
Medication Overuse Headache Study (MOH)_ $29,451 2 payments
Work Productivity Study $26,889 2 payments
Medication Overuse Headache Study (MOH) $16,829 2 payments
Phase P3 Pediatric Study (EM). $14,032 1 payment
Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound (ICHD 2018). Migraine can be further categorized according to the frequency of attacks as episodic migraine (EM) or chronic migraine (CM). This study will assess the effects of BOTOX in preventing migraine in adult participants with EM. $9,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.